Alteplase unlikely to reduce disability after mild stroke without disabling deficits
1. In this randomized controlled trial, administration of alteplase within 3 hours of mild stoke did not lead to a ...
Tag: alteplase
Low-dose alteplase did not show differential benefits across age, ethnicity or severity of stroke compared with standard-dose
1. In this secondary analysis of the Enhanced Control of Hypertension and Thrombolysis Stroke Study (ENCHANTED), there were no significant ...
Endovascular stroke treatment reduces mortality
1. Patients with acute ischemic stroke presenting with proximal vessel occlusion, adequate collateral circulation, and small infarct size who received ...
Perfusion-guided endovascular stroke treatment improves outcomes
1. Among patients with large vessel ischemic stroke and evidence of salvageable brain tissue on computed tomography (CT) perfusion imaging, ...
Early alteplase treatment leads to better stroke outcomes regardless of age or stroke severity
1. Alteplase (recombinant tissue plasminogen activator, or rtPA) administration within 4.5 hours hours following the onset of an ischemic stroke ...